G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2006
12/14/2006	US20060280737 Reducing body weight or food intake ; binding to antibody
12/14/2006	US20060280733 Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence
12/14/2006	US20060280727 Dendritic cell isolation methods
12/14/2006	US20060280725 Compositions and methods of treating and diagnosing hepatoma
12/14/2006	US20060280723 Interferon for treating or preventing a coronaviral infection
12/14/2006	US20060280684 Using lymphocyte gene expression profiles as diagnostic indicator of asthma, allergic and autoimmune disorders
12/14/2006	US20060280683 Method of identifying inhibitors of GADD45 polypeptide activity, and inhibitors of such activity
12/14/2006	US20060280679 Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
12/14/2006	US20060280654 Multiwell Apparatus
12/14/2006	US20060280652 Long wavelength thiol-reactive fluorophores
12/14/2006	US20060279725 Aggregometer with near ultraviolet light source
12/14/2006	US20060279724 Micro-volumetric blood radioactivity counter
12/14/2006	US20060278538 Methods and devices for controlling the impact of short circuit faults on co-planar electrochemical sensors
12/14/2006	US20060278525 Biosensor strips and methods of preparing same
12/14/2006	US20060278025 Time domain resolving chemical sampler using sorbent material
12/14/2006	US20060278024 Testing apparatus and method of deriving young's modulus from tensile stress/strain relationships
12/14/2006	US20060277978 Viscosity sensor system
12/14/2006	US20060277977 Multi-sensor system for fluid monitoring with selective exposure of sensors
12/14/2006	US20060277971 Method and apparatus for detecting exhaust gas sensor defect
12/14/2006	DE3943870B4 Lumineszierend markierte Komponente einer wässrigen Flüssigkeit Luminescent labeled component of an aqueous liquid
12/14/2006	DE10361927B4 Ionenkanal-Sensorarray Ion-channel sensor array
12/14/2006	DE102006025714A1 Vorrichtung und Verfahren zum Unterscheiden unter Lateralflussuntersuchungs-Testindikatoren Apparatus and method for discriminating among Lateralflussuntersuchungs test indicators
12/14/2006	DE102005027172A1 Extraction of proteins, protein fragments or peptides from biological samples comprises using an ionic liquid as the extractant
12/14/2006	DE102005026540A1 Verfahren und Vorrichtung zur Handhabung von Objekten Method and apparatus for handling objects
12/14/2006	DE102005026485A1 Hydrophile Nanoteilchen mit funktionellen Oberflächengruppen, deren Herstellung und Verwendung Hydrophilic nanoparticles with surface functional groups, their preparation and use
12/14/2006	DE102005026151A1 Cylindrical model to determine the progress of a reaction or process at a pre-determined depth over an extended period
12/14/2006	DE102005026081A1 Extraction of immunologically active polymers, comprises prepurifying and enzymatically releasing the active polymers from mushroom cell walls by different chitinase
12/14/2006	DE10111457B4 Diagnoseeinrichtung Diagnostic device
12/14/2006	CA2650841A1 Method of profiling a cell population
12/14/2006	CA2620465A1 Specific binding sites in collagen for integrins and use thereof
12/14/2006	CA2611861A1 Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (pd-1) pathway
12/14/2006	CA2611728A1 Methods for the identification, assessment, and treatment of patients with cancer therapy
12/14/2006	CA2611726A1 Pharmaceutical compositions containing sc(fv)2
12/14/2006	CA2611591A1 Analysis of tissue samples surrounding malignancies
12/14/2006	CA2611452A1 Method of manufacturing probe-immobilized carrier
12/14/2006	CA2611445A1 Method for evaluation of compound using rsk1
12/14/2006	CA2611286A1 Method for testing substances or mixtures of substances, use of said method and corresponding test kits
12/14/2006	CA2611206A1 Detection of encephalopathies by amplifying the oligomerisation of prpsc
12/14/2006	CA2611091A1 Biosensor strips and methods of preparing same
12/14/2006	CA2610976A1 Use of stefin a as a scaffold protein
12/14/2006	CA2610875A1 Assays based on liquid flow over arrays
12/14/2006	CA2610771A1 Anti-trkb monoclonal antibodies and uses thereof
12/14/2006	CA2610709A1 Transgenic models for different genes and their use for gene characterization
12/14/2006	CA2610268A1 Methods and composition for diagnosis of neurological disorders in body fluids
12/14/2006	CA2609999A1 Stable and soluble antibodies inhibiting tnfalpha
12/14/2006	CA2609573A1 Diagnostic-nanosensor and its use in medicine
12/14/2006	CA2607264A1 Use of nt-proanp and nt-probnp for diagnosing cardiac diseases
12/14/2006	CA2604087A1 Lipase polypeptide
12/14/2006	CA2549493A1 Device for analysing a body fluid
12/13/2006	EP1731913A2 Methods and compositions for determining lipid peroxidation levels in oxidant stress syndromes and diseases
12/13/2006	EP1731912A2 Peptide selection method
12/13/2006	EP1731911A1 Method of detecting encephalopathies
12/13/2006	EP1731910A1 Use of NT-proANP and NT-proBNP for diagnosing cardiac diseases
12/13/2006	EP1731909A1 Immobilization vehicle, method of treating vehicle and continuous vehicle treating apparatus
12/13/2006	EP1731908A2 Labeling substance and chimera substance, process for preparing these substances, and method of biosubstance trapping, structural analysis or/and identification with use of the labeling substance
12/13/2006	EP1731907A1 Method of detecting allergen
12/13/2006	EP1731906A1 Device for determining the corresponding air humidity of a material sample and for determining the moisture content of this same material sample in a closed system
12/13/2006	EP1731905A1 Mass analysis method using fine metal particles
12/13/2006	EP1731619A2 Tumour markers
12/13/2006	EP1731611A2 Eimeria hydrophilic polypeptides as vaccines
12/13/2006	EP1731608A1 Marker gene for arthrorheumatism test
12/13/2006	EP1731605A1 Cancer antigen peptides derived from wt1
12/13/2006	EP1731603A1 Probes for detecting protein nuclear migration and method of detecting and quantifying protein nuclear migration using the same
12/13/2006	EP1731602A1 Pharmaceutical composition for lowering blood sugar level
12/13/2006	EP1731601A1 INACTIVE Ca2+/CALMODULIN-DEPENDENT PROTEIN KINASE II alpha KNOCKIN ANIMAL AND KNOCKIN CELL OF THE SAME
12/13/2006	EP1731548A1 Use of fluorescent polysiloxanes in chemical sensors for detection or dosage of nitrated compounds
12/13/2006	EP1731540A1 Polymer particle
12/13/2006	EP1731529A1 Calcium ion leakage inhibitors
12/13/2006	EP1731525A1 Nucleotide derivatives and dna microarray
12/13/2006	EP1731517A1 Linker compound, ligand complex and process for producing them
12/13/2006	EP1731455A1 Detection and device for detecting recording media
12/13/2006	EP1731443A1 Container with lid
12/13/2006	EP1731297A1 Corrugated board machine
12/13/2006	EP1731161A1 Compositions for the treatment of diseases associated with elevated sphingolipid concentrations
12/13/2006	EP1731030A1 Method of constructing animal having cancer cells transplanted thereinto
12/13/2006	EP1730537A2 Diagnostics and therapeutics for diseases associated with protein kinase, cgmp-dependent, type i (prkg1)
12/13/2006	EP1730536A2 Methods for detecting calcium ion influx
12/13/2006	EP1730535A2 Hausp-mdm2 interaction and uses thereof
12/13/2006	EP1730534A2 Compositions and methods for treating lung cancer
12/13/2006	EP1730533A1 Adam8 as tumor marker and therapeutic target for non-small cell lung cancer
12/13/2006	EP1730532A2 Method to detect molecular binding by surface-enhanced raman spectroscopy
12/13/2006	EP1730531A2 Electrode
12/13/2006	EP1730530A1 Analytical platform and method for generating protein expression profiles of cell populations
12/13/2006	EP1730529A2 Methods of evaluating efficacy of an immune response by assessing alpha-1 integrin expression
12/13/2006	EP1730528A2 Method of optimizing treatment with interferon-tau
12/13/2006	EP1730527A2 RM2 ANTIGEN (ß1,4-GALNAC-DISIALYL-LC4) AS PROSTATE CANCER-ASSOCIATED ANTIGEN
12/13/2006	EP1730526A2 Fluorescence polarization assay
12/13/2006	EP1730525A1 Immunoassays for everolimus
12/13/2006	EP1730524A1 Biosensors for detecting bond rupture
12/13/2006	EP1730523A1 Use of a composition which regulates oxidation/reduction reactions intracellularly and/or extracellularly in a staining or sorting process of spermatozoa
12/13/2006	EP1730522A2 Methods for treating dermatological conditions in a patient
12/13/2006	EP1730521A2 The use of gametes and pre-implanted embryos for determining the toxicity of biologically active compounds
12/13/2006	EP1730520A2 Diagnostics and therapeutics for diseases associated with peroxisome proliferator activated receptor delta (ppard)
12/13/2006	EP1730519A1 Method, chip, device and system for collection of biological particles
12/13/2006	EP1730518A2 Method, chip, device and integrated system for detection biological particles
12/13/2006	EP1730517A2 Sample age monitoring devices and methods
12/13/2006	EP1730516A1 Method and device for evaluation of pharmaceutical compositions
12/13/2006	EP1730515A1 Apparatus for inspecting food items
12/13/2006	EP1730514A2 High throughput screening methods for lubricating oil compositions
12/13/2006	EP1730505A2 Method and device for the measurement and on-line characterisation of a biomass in a lactic acid bacteria fermentation process and associated control method

1 ... 1762 1763 1764 1765 1766 1767 1768 1769 1770 1771 1772 1773 1774 1775 1776 1777 1778 1779 1780 1781 1782 ... 3937